Previous close | 11.17 |
Open | 11.36 |
Bid | 10.77 x 400 |
Ask | 10.85 x 100 |
Day's range | 10.76 - 11.36 |
52-week range | 6.50 - 14.74 |
Volume | |
Avg. volume | 116,633 |
Market cap | 214.639M |
Beta (5Y monthly) | 1.92 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript May 11, 2024 INmune Bio, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to the INmune Bio First Quarter 2024 Earnings Call. At the end of the […]
INmune Bio ( NASDAQ:INMB ) First Quarter 2024 Results Key Financial Results Net loss: US$11.0m (loss widened by 69...
Potential INmune Bio, Inc. ( NASDAQ:INMB ) shareholders may wish to note that the Independent Director, Scott Juda...